Orion SA (OEC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

OEC Orion SA

Watchlist

18.250
-0.750-3.95%

Trading Dec 4 14:10 ET

1.05BMarket Cap33.80P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Orion S.A.'s (NYSE:OEC) 25% Jump Shows Its Popularity With Investors
Simply Wall StDec 3 05:07 ET
Investors in Orion (NYSE:OEC) Have Unfortunately Lost 22% Over the Last Year
Yahoo FinanceNov 25 14:31 ET
Orion S.A. to Participate in Baird's Global Industrial Conference
BusinesswireNov 11 16:15 ET
Orion Upgraded, Cabot Downgraded at J.P. Morgan
Seeking AlphaNov 11 09:15 ET
Orion Analyst Ratings
BenzingaNov 11 07:23 ET · Ratings
J.P. Morgan Upgrades Orion SA(OEC.US) to Buy Rating, Raises Target Price to $21
Moomoo NewsNov 11 05:33 ET · Ratings

Comments

Stock_Drift

Oct 20 17:16

$AERIUS (AERS.US)$ $Alphabet-C (GOOG.US)$ $Orion SA (OEC.US)$

Moomoo AI

Mar 22 06:11

Orion is undervalued compared to peers, with high volatility presenting buying opportunities. Optimistic future earnings could boost cash flows and share value, but financial health is also crucial.

Is Orion S.A. (NYSE:OEC) Potentially Undervalued?

Moomoo Breakfast US

Jun 17, 2022 07:29

Columns Today's pre-market stock movers: X, REV, ROKU, BHC and more

Gainers:
• $Revlon (REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $United States Steel (X.US)$ +6.4% (issues upside EPS guidance),
• $Ellington Financial (EFC.US)$ +5% (reports book value per share)
• $Aurora Mobile (JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Citi Trends (CTRN.US)$ +4.4% (names new CFO)
• $Roku Inc (ROKU.US)$ +4.2% (ROKU an...

Moomoo Breakfast US

Mar 31, 2022 07:53

Columns Today's pre-market stock movers: CLVS, PATH, DARE and more

Gainers:
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...

Trending US Stocks

Symbol Mini Chart % Chg

NEPTUNE DIGITAL ASSETS CORP

Unlock the Full List